1. Home
  2. ZYXI vs NVNO Comparison

ZYXI vs NVNO Comparison

Compare ZYXI & NVNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ZYXI
  • NVNO
  • Stock Information
  • Founded
  • ZYXI 1996
  • NVNO 1987
  • Country
  • ZYXI United States
  • NVNO United States
  • Employees
  • ZYXI N/A
  • NVNO N/A
  • Industry
  • ZYXI Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • NVNO Medical/Dental Instruments
  • Sector
  • ZYXI Health Care
  • NVNO Health Care
  • Exchange
  • ZYXI Nasdaq
  • NVNO Nasdaq
  • Market Cap
  • ZYXI 72.3M
  • NVNO 71.0M
  • IPO Year
  • ZYXI N/A
  • NVNO N/A
  • Fundamental
  • Price
  • ZYXI $2.26
  • NVNO $5.04
  • Analyst Decision
  • ZYXI Buy
  • NVNO
  • Analyst Count
  • ZYXI 3
  • NVNO 0
  • Target Price
  • ZYXI $5.50
  • NVNO N/A
  • AVG Volume (30 Days)
  • ZYXI 132.8K
  • NVNO 140.0K
  • Earning Date
  • ZYXI 07-31-2025
  • NVNO 08-08-2025
  • Dividend Yield
  • ZYXI N/A
  • NVNO N/A
  • EPS Growth
  • ZYXI N/A
  • NVNO N/A
  • EPS
  • ZYXI N/A
  • NVNO N/A
  • Revenue
  • ZYXI $172,401,000.00
  • NVNO N/A
  • Revenue This Year
  • ZYXI N/A
  • NVNO N/A
  • Revenue Next Year
  • ZYXI $19.55
  • NVNO N/A
  • P/E Ratio
  • ZYXI N/A
  • NVNO N/A
  • Revenue Growth
  • ZYXI N/A
  • NVNO N/A
  • 52 Week Low
  • ZYXI $1.66
  • NVNO $2.03
  • 52 Week High
  • ZYXI $9.42
  • NVNO $5.81
  • Technical
  • Relative Strength Index (RSI)
  • ZYXI 49.49
  • NVNO 60.75
  • Support Level
  • ZYXI $2.46
  • NVNO $4.65
  • Resistance Level
  • ZYXI $2.60
  • NVNO $5.27
  • Average True Range (ATR)
  • ZYXI 0.15
  • NVNO 0.40
  • MACD
  • ZYXI 0.01
  • NVNO 0.01
  • Stochastic Oscillator
  • ZYXI 46.75
  • NVNO 61.59

About ZYXI Zynex Inc.

Zynex Inc is engaged in the manufacturing and marketing of medical devices. It operates through one primary business segment, Electrotherapy and Pain Management Products. The business activities of the company are carried out through its subsidiaries. The company designs, manufactures, and markets medical devices that treat chronic and acute pain, as well as activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company operates business as one operating segment which includes two revenue types: Devices and Supplies. Its markets Zynex-manufactured products which include NexWave, NeuroMove, InWave E-Wave, and others.

About NVNO enVVeno Medical Corporation

enVVeno Medical Corp is a late clinical-stage medical device company focused on advancing bioprosthetic (tissue-based) solutions to improve the standard of care for treating venous disease. The company's product, VenoValve, is a surgical replacement venous valve that is currently being evaluated in a U.S. pivotal study. The company is also developing a second product called enVVe, which is a non-surgical, transcatheter-based replacement venous valve. Both the products are designed to act as one-way valves to help assist in propelling blood up the veins of the leg, and back to the heart and lungs. The company has determined that it currently operates in a single segment, Medical Device development, located in a single geographic location, the United States.

Share on Social Networks: